Impact of patients' perception of COPD and treatment on adherence and health-related quality of life in real-world: Study in 53 community pharmacies

Background: Patient adherence to treatment in chronic obstructive pulmonary disease (COPD) is essential to optimize disease management. We aimed to assess the impact of patients' perception of their treatment and disease on adherence and Health-Related Quality of Life (HRQL) in patients attending a...

Full description

Bibliographic Details
Authors: López-Pintor E; Grau J; González I; Bernal-Soriano MC; Quesada JA; Lumbreras B
Format: Article
Status:Published version
Publication date:2021
Country:España
Institution:Fundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunitat Valenciana (FISABIO)
Repository:r-FISABIO. Repositorio Institucional de Producción Científica
OAI Identifier:oai:fisabio.fundanetsuite.com:p8593
Online Access:https://fisabio.portalinvestigacion.com/publicaciones/8593
Access Level:Open access
Keyword:Chronic obstructive pulmonary disease
Adherence
Persistence
Inhaler medication
Health-related quality of life
_version_ 1878731244745785344
author López-Pintor E
author2 Grau J
González I
Bernal-Soriano MC
Quesada JA
Lumbreras B
author2_role author
author
author
author
author
author_browse Bernal-Soriano MC
González I
Grau J
Lumbreras B
López-Pintor E
Quesada JA
author_facet López-Pintor E
Grau J
González I
Bernal-Soriano MC
Quesada JA
Lumbreras B
author_role author
collection r-FISABIO. Repositorio Institucional de Producción Científica
description Background: Patient adherence to treatment in chronic obstructive pulmonary disease (COPD) is essential to optimize disease management. We aimed to assess the impact of patients' perception of their treatment and disease on adherence and Health-Related Quality of Life (HRQL) in patients attending a community pharmacy, where usually subjects have a better condition than those in clinical settings. Methods: We performed a cross-sectional study of 318 patients with COPD in treatment with inhalers in the last 3 months from 53 community pharmacies. We assessed HRQL with St George's Respiratory Questionnaire (SGRQ). Persistence was assessed from the three previous refills and adherence through the Test of Adherence to Inhalers test. Results: Persistence was achieved by 78.6% of the patients and 58.5% had good adherence. Patients having a multidose DPI and those with MDI showed a 2.8-fold and 4.1-fold increased association, respectively, with intermediate/poor adherence in comparison with those having a single dose DPI. Those patients who did not have knowledge about COPD (aOR 2.106, p = 0.006) and those who thought that the inhaler effectiveness was fair/poor (aOR 2.361, p = 0.006) were more likely to have intermediate/poor adherence. Overall SGRQ score was significantly worse in patients with intermediate/poor adherence (p = 0.036) and in those who thought the inhaler's effectiveness was fair/poor (p < 0.001). Conclusions: The type of inhaler and patients' knowledge and perceptions of their disease and treatment were associated with good adherence and higher HRQL. Clinicians should promote shared-decision making in the choice of inhaler depending on patients' individual abilities and beliefs.
eu_rights_str_mv openAccess
format article
id ES_2bb3ceca2cce7ed528b1d150bd5dcc4a
institution Fundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunitat Valenciana (FISABIO)
instname_str Fundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunitat Valenciana (FISABIO)
network_acronym_str ES
network_name_str España
oai_identifier_str oai:fisabio.fundanetsuite.com:p8593
publishDate 2021
publishDateSort 2021
publisher W B SAUNDERS CO LTD
publisherStr W B SAUNDERS CO LTD
reponame_str r-FISABIO. Repositorio Institucional de Producción Científica
spelling Impact of patients' perception of COPD and treatment on adherence and health-related quality of life in real-world: Study in 53 community pharmacies López-Pintor E Grau J González I Bernal-Soriano MC Quesada JA Lumbreras B Chronic obstructive pulmonary disease Adherence Persistence Inhaler medication Health-related quality of life Background: Patient adherence to treatment in chronic obstructive pulmonary disease (COPD) is essential to optimize disease management. We aimed to assess the impact of patients' perception of their treatment and disease on adherence and Health-Related Quality of Life (HRQL) in patients attending a community pharmacy, where usually subjects have a better condition than those in clinical settings. Methods: We performed a cross-sectional study of 318 patients with COPD in treatment with inhalers in the last 3 months from 53 community pharmacies. We assessed HRQL with St George's Respiratory Questionnaire (SGRQ). Persistence was assessed from the three previous refills and adherence through the Test of Adherence to Inhalers test. Results: Persistence was achieved by 78.6% of the patients and 58.5% had good adherence. Patients having a multidose DPI and those with MDI showed a 2.8-fold and 4.1-fold increased association, respectively, with intermediate/poor adherence in comparison with those having a single dose DPI. Those patients who did not have knowledge about COPD (aOR 2.106, p = 0.006) and those who thought that the inhaler effectiveness was fair/poor (aOR 2.361, p = 0.006) were more likely to have intermediate/poor adherence. Overall SGRQ score was significantly worse in patients with intermediate/poor adherence (p = 0.036) and in those who thought the inhaler's effectiveness was fair/poor (p < 0.001). Conclusions: The type of inhaler and patients' knowledge and perceptions of their disease and treatment were associated with good adherence and higher HRQL. Clinicians should promote shared-decision making in the choice of inhaler depending on patients' individual abilities and beliefs. W B SAUNDERS CO LTD https://fisabio.portalinvestigacion.com/publicaciones/8593
spellingShingle Impact of patients' perception of COPD and treatment on adherence and health-related quality of life in real-world: Study in 53 community pharmacies
López-Pintor E
Chronic obstructive pulmonary disease
Adherence
Persistence
Inhaler medication
Health-related quality of life
status_str publishedVersion
title Impact of patients' perception of COPD and treatment on adherence and health-related quality of life in real-world: Study in 53 community pharmacies
title_full Impact of patients' perception of COPD and treatment on adherence and health-related quality of life in real-world: Study in 53 community pharmacies
title_fullStr Impact of patients' perception of COPD and treatment on adherence and health-related quality of life in real-world: Study in 53 community pharmacies
title_full_unstemmed Impact of patients' perception of COPD and treatment on adherence and health-related quality of life in real-world: Study in 53 community pharmacies
title_short Impact of patients' perception of COPD and treatment on adherence and health-related quality of life in real-world: Study in 53 community pharmacies
title_sort Impact of patients' perception of COPD and treatment on adherence and health-related quality of life in real-world: Study in 53 community pharmacies
topic Chronic obstructive pulmonary disease
Adherence
Persistence
Inhaler medication
Health-related quality of life
topic_facet Chronic obstructive pulmonary disease
Adherence
Persistence
Inhaler medication
Health-related quality of life
url https://fisabio.portalinvestigacion.com/publicaciones/8593